Follow The Filings

DHC Diversified Healthcare Trust

Real Estate, filed as DIVERSIFIED HEALTHCARE TR (COM SH BEN INT), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.7%
  • $60M
  • 1 add

In 2026 Q2 Davidson Kempner Capital Management added to Diversified Healthcare Trust.

Who owns this now

Largest portfolio weights among holders, up to 0.7% (Davidson Kempner Capital Management). Not free-float ownership.

  1. Davidson Kempner Capital Mana... Add 0.71%

Who owns DHC

Sorted by value, long equity only, as of 2026 Q2.

History
Davidson Kempner Capital Management 0.71%, was 0.57% Add +2.6% 6,409,530 $60M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DHC insider trades
  • $98K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Christopher J. Bilotto CEO
    Buy
    $98K 20,000 shares at $4.89 +8.1% to stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants and 3 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,8.01 Filing Doc
8-K 1.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.41B $1.5B $1.54B
Net income -$293.57M -$370.26M -$285.89M
Net margin * -20.8% -24.8% -18.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $5.45B $5.14B $4.36B
Total equity $2.34B $1.96B $1.67B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $10.48M $112.22M -$19.62M
Cash from investing -$202.11M -$187.02M $483.57M
Cash from financing -$249.71M -$22.31M -$492.01M
Net change in cash -$441.34M -$97.11M -$28.06M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf